Renal Cell Carcinoma News and Research

RSS
Renal cell carcinoma (RCC, also known as hypernephroma) is a kidney cancer that originates in the lining of the proximal convoluted tubule, the very small tubes in the kidney that filter the blood and remove waste products.
Study Identifies Microproteins as Key Source of Tumor-Specific Antigens in Liver Cancer

Study Identifies Microproteins as Key Source of Tumor-Specific Antigens in Liver Cancer

Study Identifies Three Distinct Subtypes of Clear Cell Renal Cell Carcinoma Using Radiomics and Transcriptomics

Study Identifies Three Distinct Subtypes of Clear Cell Renal Cell Carcinoma Using Radiomics and Transcriptomics

Study Reveals Key Insights Into the Evolution of Tumor Microenvironment in Gastric Cancer

Study Reveals Key Insights Into the Evolution of Tumor Microenvironment in Gastric Cancer

Genes can be used to better predict the likelihood of kidney cancer recurrence

Genes can be used to better predict the likelihood of kidney cancer recurrence

Researchers created ultrasound-guided microbubbles to enhance immunotherapy performance

Researchers created ultrasound-guided microbubbles to enhance immunotherapy performance

Researchers determine the novel medical target of angiogenesis for ccRCC patients

Researchers determine the novel medical target of angiogenesis for ccRCC patients

Immune cell patterns can help predict kidney cancer patients' response to immunotherapy

Immune cell patterns can help predict kidney cancer patients' response to immunotherapy

Targeted drug shows promise against brain metastases from kidney cancer

Targeted drug shows promise against brain metastases from kidney cancer

New technology efficiently delivers immune checkpoint inhibitors for treating brain tumors

New technology efficiently delivers immune checkpoint inhibitors for treating brain tumors

Natural killer cells target breast cancer using the body’s immune system

Natural killer cells target breast cancer using the body’s immune system

Immunotherapy following kidney cancer surgery prolonged disease-free survival rates

Immunotherapy following kidney cancer surgery prolonged disease-free survival rates

Genetic changes in tumors could help predict patient's response to immunotherapy drugs

Genetic changes in tumors could help predict patient's response to immunotherapy drugs

Combination treatment improves outcomes in advanced kidney cancer patients

Combination treatment improves outcomes in advanced kidney cancer patients

In-depth study of kidney tumors reveals novel markers of response to immunotherapy

In-depth study of kidney tumors reveals novel markers of response to immunotherapy

Greater gut microbial diversity in kidney cancer patients linked to better treatment outcomes

Greater gut microbial diversity in kidney cancer patients linked to better treatment outcomes

Total-body dynamic PET scans can produce high-quality images of metastatic cancer

Total-body dynamic PET scans can produce high-quality images of metastatic cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.